Researchers Visualize Second Bonding Site for Popular Breast Cancer Drug
June 12, 2006
Researchers at the University of Cincinnati and Lilly Research Laboratories have confirmed the existence of a second binding site on the estrogen receptor for the popular breast cancer drug tamoxifen.